These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19422008)

  • 21. Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding.
    Glendorf T; Sørensen AR; Nishimura E; Pettersson I; Kjeldsen T
    Biochemistry; 2008 Apr; 47(16):4743-51. PubMed ID: 18376848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering bispecificity into a single albumin-binding domain.
    Nilvebrant J; Alm T; Hober S; Löfblom J
    PLoS One; 2011; 6(10):e25791. PubMed ID: 21991353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creating small-molecule-dependent switches to modulate biological functions.
    Buskirk AR; Liu DR
    Chem Biol; 2005 Feb; 12(2):151-61. PubMed ID: 15734643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supramolecular assembly and small molecule recognition by genetically engineered protein block polymers composed of two SADs.
    Haghpanah JS; Yuvienco C; Roth EW; Liang A; Tu RS; Montclare JK
    Mol Biosyst; 2010 Sep; 6(9):1662-7. PubMed ID: 20480093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational control of inorganic adhesion in a designer protein engineered for cuprous oxide binding.
    Choe WS; Sastry MS; Thai CK; Dai H; Schwartz DT; Baneyx F
    Langmuir; 2007 Nov; 23(23):11347-50. PubMed ID: 17918983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide.
    Diana D; Ziaco B; Colombo G; Scarabelli G; Romanelli A; Pedone C; Fattorusso R; D'Andrea LD
    Chemistry; 2008; 14(14):4164-6. PubMed ID: 18384035
    [No Abstract]   [Full Text] [Related]  

  • 28. The creation of a novel fluorescent protein by guided consensus engineering.
    Dai M; Fisher HE; Temirov J; Kiss C; Phipps ME; Pavlik P; Werner JH; Bradbury AR
    Protein Eng Des Sel; 2007 Feb; 20(2):69-79. PubMed ID: 17277006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering of non-natural receptors.
    Mathonet P; Fastrez J
    Curr Opin Struct Biol; 2004 Aug; 14(4):505-11. PubMed ID: 15313246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering unnatural nucleotide specificity to probe G protein signaling.
    Vincent F; Cook SP; Johnson EO; Emmert D; Shah K
    Chem Biol; 2007 Sep; 14(9):1007-18. PubMed ID: 17884633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based stability analysis of an extremely stable dimeric DNA binding protein from Sulfolobus islandicus.
    Weininger U; Zeeb M; Neumann P; Löw C; Stubbs MT; Lipps G; Balbach J
    Biochemistry; 2009 Oct; 48(42):10030-7. PubMed ID: 19788170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel protein engineering strategy for creating highly receptor-selective mutant TNFs.
    Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Taniai M; Ohta T; Tsunoda S; Tsutsumi Y
    Biochem Biophys Res Commun; 2009 Oct; 388(4):667-71. PubMed ID: 19682974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein engineering strategies.
    Whitlow M
    Targeted Diagn Ther; 1992; 7():55-61. PubMed ID: 1633309
    [No Abstract]   [Full Text] [Related]  

  • 34. Design of a novel heme protein with a non-heme globin scaffold.
    Isogai Y; Ishida M
    Biochemistry; 2009 Sep; 48(34):8136-42. PubMed ID: 19601582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in generating functional diversity for directed protein evolution.
    Shivange AV; Marienhagen J; Mundhada H; Schenk A; Schwaneberg U
    Curr Opin Chem Biol; 2009 Feb; 13(1):19-25. PubMed ID: 19261539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure, dynamics and thermodynamics of the human centrin 2/hSfi1 complex.
    Martinez-Sanz J; Kateb F; Assairi L; Blouquit Y; Bodenhausen G; Abergel D; Mouawad L; Craescu CT
    J Mol Biol; 2010 Jan; 395(1):191-204. PubMed ID: 19857500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational design of four-helix bundle proteins that bind nonbiological cofactors.
    Lehmann A; Saven JG
    Biotechnol Prog; 2008; 24(1):74-9. PubMed ID: 18197672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobalt(II)-responsive DNA binding of a GCN4-bZIP protein containing cysteine residues functionalized with iminodiacetic acid.
    Azuma Y; Imanishi M; Yoshimura T; Kawabata T; Futaki S
    Angew Chem Int Ed Engl; 2009; 48(37):6853-6. PubMed ID: 19655361
    [No Abstract]   [Full Text] [Related]  

  • 40. Engineering an ultra-stable affinity reagent based on Top7.
    Boschek CB; Apiyo DO; Soares TA; Engelmann HE; Pefaur NB; Straatsma TP; Baird CL
    Protein Eng Des Sel; 2009 May; 22(5):325-32. PubMed ID: 19321520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.